(Q46058009)

19 December 2017

title

Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment (English)

1 reference

19 December 2017

mild cognitive impairment

main subject

Alzheimer's disease

0 references

1 reference

Ruth A Mulnard

1

1 reference

19 December 2017

Marìa M Corrada

series ordinal

2

1 reference

19 December 2017

Claudia H Kawas

series ordinal

3

1 reference

19 December 2017

publication date

1 September 2004

1 reference

19 December 2017

Current Neurology and Neuroscience Reports

published in

1 reference

19 December 2017

volume

4

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

368-373

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s11910-004-0083-8

exact match

0 references

cites work

Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

A case-control study of Alzheimer's disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Lack of postmenopausal estrogen replacement therapy and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-004-0083-8

Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus

21 January 2018

1 reference

12 December 2020

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

12 December 2020

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

12 December 2020

Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

1 reference

12 December 2020

Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats.

1 reference

12 December 2020

Estrogens: trophic and protective factors in the adult brain

1 reference

12 December 2020

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

1 reference

12 December 2020

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

12 December 2020

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

12 December 2020

Hormone replacement therapy and cognition: systematic review and meta-analysis

1 reference

12 December 2020

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

12 December 2020

A case-control study of Alzheimer's disease

1 reference

12 December 2020

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

12 December 2020

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

12 December 2020

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

12 December 2020

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

1 reference

12 December 2020

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

12 December 2020

Current concepts in mild cognitive impairment

1 reference

12 December 2020

Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease.

1 reference

12 December 2020

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

12 December 2020

Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys

1 reference

12 December 2020

Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats.

1 reference

12 December 2020

Estrogen and cognition: applying preclinical findings to clinical perspectives

1 reference

12 December 2020

Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats

1 reference

12 December 2020

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

1 reference

12 December 2020

Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys.

1 reference

12 December 2020

Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population

1 reference

12 December 2020

Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys

1 reference

12 December 2020

Incidence of dementia: does gender make a difference?

1 reference

12 December 2020

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

1 reference

12 December 2020

The prevalence of dementia: a quantitative integration of the literature

1 reference

12 December 2020

Alzheimer's disease: a study of epidemiological aspects.

1 reference

12 December 2020

Hormone therapy: physiological complexity belies therapeutic simplicity

1 reference

12 December 2020

Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys

1 reference

12 December 2020

10.1007/S11910-004-0083-8

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017